Adamas Pharmaceuticals reported 124.48M in Loan Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Adamas Pharmaceuticals ADMS:US 124.48M 1.06M
Aerie Pharmaceuticals AERI:US $ 228.19M 6.17M
Aptinyx Inc APTX:US $ 14.04M 14.04M
Flexion Therapeutics FLXN:US $ 250.5M 30.48M
GlaxoSmithKline GSK:LN 20736M 294M
Glaxosmithkline GSK:US $ 20736M 294M
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
Intra Cellular Therapies ITCI:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 40.58M 29.61M
Neurocrine Biosciences NBIX:US $ 330.7M 4.4M
Novartis NOVN:VX SF 24715M 1776M
Omeros OMER:US $ 313.02M 433K
Prothena PRTA:US 0 0
Revance Therapeutics RVNC:US $ 280.32M 0.32M
Teva Pharmaceutical TEVA:IT 21.04B 565M
Zogenix ZGNX:US $ 155.87M 2.24M